Literature DB >> 11511429

Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy.

A K Agarwal1, P Venugopalan.   

Abstract

Fourteen digitalised patients diagnosed with heart failure (NYHA Functional class II) with idiopathic dilated cardiomyopathy in chronic established atrial fibrillation were administered carvedilol in addition to their anti-heart failure medications in an attempt to improve their heart rate control. Fourteen matched patients who did not receive carvedilol acted as control subjects. Patients treated with carvedilol showed significantly reduced resting heart rates (10-36%), maximal heart rates on exercise (5-20%) and an increased exercise time (2-30%) on treadmill stress tests (all P=0.001). Ventricular ectopic activity was also diminished. This was associated with symptomatic improvement in effort intolerance and palpitations. NYHA functional class, left ventricular dimensions and ejection fractions did not improve during the study period of 3 months. Thus, addition of carvedilol to digoxin had a beneficial effect on exercise tolerance in patients with idiopathic dilated cardiomyopathy in atrial fibrillation by virtue of an improved heart rate control both at rest and on exercise. Carvedilol was well tolerated despite impaired myocardial function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511429     DOI: 10.1016/s1388-9842(01)00130-1

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  4 in total

Review 1.  Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.

Authors:  Giuseppe Boriani; Mauro Biffi; Igor Diemberger; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Therapeutic interventions for heart failure with preserved ejection fraction: A summary of current evidence.

Authors:  Muhammad Asrar ul Haq; Chiew Wong; Vivek Mutha; Nagesh Anavekar; Kwang Lim; Peter Barlis; David L Hare
Journal:  World J Cardiol       Date:  2014-02-26

3.  Oral carvedilol in escalating doses in the acute treatment of atrial fibrillation.

Authors:  Ravi Venkatachelam Chitrapu; Pentakota Ramana Rao; Gangireddy Venkateswara Reddy
Journal:  J Pharmacol Pharmacother       Date:  2014-10

4.  Heart rate dynamics during a treadmill cardiopulmonary exercise test in optimized beta-blocked heart failure patients.

Authors:  Vitor Oliveira Carvalho; Guilherme Veiga Guimarães; Emmanuel Gomes Ciolac; Edimar Alcides Bocchi
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.